Related Experiment Videos
Indirect active-site titration of plasminogen activators
1University of Cincinnati, Department of Internal Medicine, Ohio 45267-0585.
Analytical Biochemistry
|April 1, 1988
Summary
A new assay accurately measures active tissue plasminogen activator (TPA) and urokinase (UK) concentrations using trypsin standards and a specific inhibitor. This method quantizes less than 20 ng of activator, aiding in specific activity and kinetic constant determination.
Area of Science:
- Biochemistry
- Enzymology
- Analytical Chemistry
Background:
- Tissue plasminogen activator (TPA) and urokinase (UK) are crucial serine proteases involved in fibrinolysis.
- Accurate quantification of active TPA and UK is essential for therapeutic applications and research.
- Existing methods may lack sensitivity or specificity for determining active concentrations.
Purpose of the Study:
- To develop a sensitive and accurate method for determining the molar concentration of active tissue plasminogen activator (TPA) and urokinase (UK).
- To enable the calculation of specific activity for commercial TPA and UK samples.
- To facilitate the determination of kinetic constants for plasma activator inhibitors.
Main Methods:
- Development of a back-titration assay using a calibrated trypsin standard and a chloromethyl ketone inhibitor.
- Calibration of trypsin and inhibitor standards employing a guanidinobenzoyl ester active-site titrant.
- Application of the method for assaying commercial TPA and UK samples.
Main Results:
- The developed method accurately determines the molar concentration of active TPA and UK.
- Quantification of less than 20 ng of activator is achievable with high accuracy.
- The assay is suitable for calculating specific activity and determining inhibitor kinetic constants.
Conclusions:
- A novel and sensitive back-titration method has been established for active TPA and UK quantification.
- This assay provides a reliable tool for biochemical and pharmacological studies involving fibrinolytic enzymes.
- The method supports precise characterization of TPA and UK preparations and their interactions with inhibitors.